Company profile

Ticker
VNRX
Exchange
CEO
Cameron John Reynolds
Employees
Incorporated in
Location
Fiscal year end
Former names
Standard Capital Corp
SEC CIK
IRS number
911949078

VNRX stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

7 May 20
15 Jul 20
31 Dec 20

News

Company financial data Financial data

Quarter (USD) Mar 20 Dec 19 Sep 19 Jun 19
Revenue 544 0 17.1K
Net income -5.86M -3.5M -4.18M -4.16M
Diluted EPS -0.14 -0.08 -0.1 -0.11
Net profit margin -1077084% -24455%
Operating income -5.87M -3.72M -4.18M -4.12M
Net change in cash -5M -2.73M 1.19M 2.34M
Cash on hand 11.97M 16.97M 19.7M 18.51M
Annual (USD) Dec 19 Dec 18 Dec 17 Dec 16
Revenue 17.1K
Net income -16.1M -18.01M -14.77M -11.91M
Diluted EPS -0.41 -0.57 -0.56 -0.52
Net profit margin -94169%
Operating income -16.04M -17.9M -14.7M -12.43M
Net change in cash 3.54M 3.31M -11.56M 15.76M
Cash on hand 16.97M 13.43M 10.12M 21.68M

Financial data from VolitionRX earnings reports

Date Owner Security Transaction Code 10b5-1 $Price #Shares $Value #Remaining
22 May 20 Reynolds Cameron John Common Stock Buy Aquire P No 2.75 4,000 11K 1,126,273
13 Apr 20 Reynolds Cameron John Stock Option Common Stock Grant Aquire A No 3.6 85,000 306K 85,000
13 Apr 20 Micallef Jacob Vincent Stock Option Common Stock Grant Aquire A No 3.6 70,000 252K 70,000
13 Apr 20 Faulkes Martin Charles Stock Option Common Stock Grant Aquire A No 3.6 70,000 252K 70,000
13 Apr 20 Vanston David Cecil Stock Option Common Stock Grant Aquire A No 3.6 60,000 216K 60,000
7.2% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 31 36 -13.9%
Opened positions 7 8 -12.5%
Closed positions 12 3 +300.0%
Increased positions 6 6
Reduced positions 2 8 -75.0%
13F shares
Current Prev Q Change
Total value 10.37M 15M -30.8%
Total shares 3.33M 3.16M +5.4%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Lagoda Investment Management 1.85M $5.74M +1.5%
Vanguard 321.26K $1M 0.0%
Bridgeway Capital Management 224.4K $698K 0.0%
MS^L Morgan Stanley 220.63K $686K +9.9%
Geode Capital Management 204.83K $637K 0.0%
Millennium Management 146.11K $454K NEW
Advisor 56.27K $176K NEW
FRLG Goldman Sachs 53.57K $167K NEW
NTRS Northern Trust 48.94K $152K +39.6%
Jane Street 30.73K $96K NEW
Largest transactions
Shares Bought/sold Change
Millennium Management 146.11K +146.11K NEW
Advisor 56.27K +56.27K NEW
FRLG Goldman Sachs 53.57K +53.57K NEW
Renaissance Technologies 0 -52.3K EXIT
LTSH Ladenburg Thalmann Financial Services 0 -36.5K EXIT
Jane Street 30.73K +30.73K NEW
Lagoda Investment Management 1.85M +26.65K +1.5%
Aristides Capital 0 -23.05K EXIT
BAC Bank of America 28.82K +22.82K +380.0%
ExodusPoint Capital Management 0 -19.91K EXIT

Financial report summary

?
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: accruedby, accurately, acknowledged, advertising, aforementioned, agreed, agreementthrough, announced, antibody, assumption, avoid, broker, capable, China, chromatin, committed, Companyraised, confidence, constitute, contact, director, disruption, distancing, diversion, drug, duration, economic, emergence, employment, enrolling, evidenced, evolve, exact, expertise, exquisite, extended, founder, fully, GmbH, health, healthcare, hired, hiring, holdback, hospital, immunoassay, imposed, inability, installment, interruption, introduced, isolate, key, kind, knowledge, leading, led, legend, level, medical, member, mitigate, mitigating, mitigation, monthly, national, observe, Octamer, organization, outbreak, pandemic, partner, passed, pharmaceutical, policy, predict, predicted, produce, product, program, prohibit, prolonged, provision, publicly, quarantine, quickly, rapidly, reagent, recession, recombinant, recommend, recommended, recruited, recruiting, redefine, Regulation, remote, remotely, renamed, representing, resolve, response, restricted, resume, retired, return, serving, set, sharp, shipped, site, slowdown, social, solicitation, Specialist, spread, stable, step, strain, structure, subsided, supporting, surfaced, synthetic, TAMU, therapeutic, thereon, training, transfer, travel, treat, treated, trial, ultimate, uncertain, uncertainty, underwriting, unprecedented, virtue, visitor, volume, wide, Wuhan
Removed: accessible, acid, adjustment, aim, allocated, amplifying, analyze, Asia, assay, asymptomatic, billion, biomarker, bisulfite, bring, CEA, cell, chain, chemically, chromosome, circulating, close, conversion, ctDNA, decreased, detectable, discarding, discovery, earlier, ELISA, enable, exponentially, extracting, extremely, FASB, faster, FDA, fewer, focusing, fragment, full, globally, guidance, histone, hope, immunosorbent, implementation, improve, intact, largest, launch, line, lung, modified, multiple, November, nucleic, nucleosome, optional, pancreatic, partially, pathway, plasma, polymerase, portion, prevalence, prevalent, prostate, protein, PSA, quantification, reaction, referenced, requiring, researching, rest, restated, retained, retrospective, route, routine, save, sequencing, serum, significantly, simplistic, software, spectrometry, sputum, stockholder, symptomatic, target, targeted, temporarily, tissue, updated, urine, USDA, valuable